USS Investment Management Ltd lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 10.4% during the 3rd quarter, Holdings Channel reports. The firm owned 84,022 shares of the biotechnology company’s stock after purchasing an additional 7,900 shares during the period. USS Investment Management Ltd’s holdings in Axon Enterprise were worth $35,507,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of AXON. Private Advisor Group LLC increased its stake in Axon Enterprise by 71.8% in the third quarter. Private Advisor Group LLC now owns 15,382 shares of the biotechnology company’s stock valued at $6,499,000 after acquiring an additional 6,426 shares during the last quarter. Ieq Capital LLC boosted its holdings in shares of Axon Enterprise by 37.4% in the 3rd quarter. Ieq Capital LLC now owns 903 shares of the biotechnology company’s stock valued at $382,000 after purchasing an additional 246 shares in the last quarter. OneAscent Financial Services LLC acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at $229,000. Stephens Investment Management Group LLC boosted its holdings in shares of Axon Enterprise by 15.0% in the 3rd quarter. Stephens Investment Management Group LLC now owns 189,916 shares of the biotechnology company’s stock valued at $80,243,000 after purchasing an additional 24,706 shares in the last quarter. Finally, Voya Investment Management LLC increased its stake in shares of Axon Enterprise by 17.4% in the 3rd quarter. Voya Investment Management LLC now owns 256,328 shares of the biotechnology company’s stock valued at $108,304,000 after purchasing an additional 37,964 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.
Insiders Place Their Bets
In other news, insider Isaiah Fields sold 1,017 shares of Axon Enterprise stock in a transaction on Friday, September 11th. The shares were sold at an average price of $480.45, for a total value of $488,617.65. Following the completion of the sale, the insider owned 56,264 shares in the company, valued at $27,032,038.80. The trade was a 1.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the transaction, the president owned 296,974 shares in the company, valued at $170,590,774.82. The trade was a 5.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 27,792 shares of company stock worth $15,214,581. Corporate insiders own 4.20% of the company’s stock.
Analyst Ratings Changes
AXON has been the subject of a number of research analyst reports. Needham & Company LLC lowered their price target on Axon Enterprise from $750.00 to $500.00 and set a “buy” rating for the company in a report on Friday, November 6th. TD Cowen reduced their price objective on Axon Enterprise from $825.00 to $800.00 and set a “buy” rating on the stock in a research note on Monday, October 26th. Piper Sandler restated an “overweight” rating and issued a $540.00 price target (down from $561.00) on shares of Axon Enterprise in a research note on Friday, November 6th. JPMorgan Chase & Co. reduced their price objective on Axon Enterprise from $755.00 to $610.00 and set an “overweight” rating on the stock in a research report on Friday, November 6th. Finally, Morgan Stanley upped their price target on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Thirteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $612.18.
View Our Latest Report on AXON
Axon Enterprise Stock Up 2.1%
Shares of Axon Enterprise stock opened at $306.98 on Friday. The stock’s 50-day moving average is $402.24 and its 200 day moving average is $463.73. Axon Enterprise, Inc has a one year low of $291.11 and a one year high of $665.07. The firm has a market cap of $25.00 billion, a price-to-earnings ratio of 98.39, a PEG ratio of 7.28 and a beta of 1.48. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.00 and a quick ratio of 2.60.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its earnings results on Friday, November 6th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The business had revenue of $908.55 million during the quarter, compared to the consensus estimate of $934.33 million. During the same quarter in the previous year, the firm posted $1.17 earnings per share. The company’s revenue for the quarter was up 27.8% compared to the same quarter last year. Equities research analysts anticipate that Axon Enterprise, Inc will post 1.65 EPS for the current year.
Key Axon Enterprise News
Investors following AXON have been watching these news items:
- Positive Sentiment: Axon announced new deployments and expansions with state and local agencies nationwide, covering less-lethal weapons, cameras, drones, real-time operations and AI tools. The news supports the view that agencies continue adopting Axon’s broader technology platform. Connected for Safety: How State and Local Agencies Across the Country Are Modernizing Public Safety with Axon
- Positive Sentiment: Siyata PTT joined Axon Arc as its inaugural partner, adding a mission-critical communications provider to Axon’s partner ecosystem. Siyata PTT Joins Axon Arc as Inaugural Partner
- Negative Sentiment: The report also cited 156 open-market insider sales and no insider purchases over the past six months. That pattern could weigh on sentiment, though sales alone do not establish insiders’ outlook.
Axon Enterprise Company Profile
Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.
Featured Articles
- Five stocks we like better than Axon Enterprise
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
